Rodriguez, conducted a cohort study involving 125,474 patients who started GLP-1 medications, including Victoza (liraglutide), Ozempic and Wegovy, and Mounjaro and Zepbound between January 1, 2018 and December 31, 2023
These questionnaires sometimes only evaluated your BMI and health history (which lets be real, not everyone is a great historian), with complete disregard for family history, thorough exams, or even basic medical history taking practices
The company states it does not currently serve Alabama, Alaska, Arkansas, Hawaii, Massachusetts, Missouri, New Mexico, New York, South Carolina, or Virginia, and notes it is "working to expand availability to more states." State availability may change
What Will Happen to GLP-1 Coverage After the Bridge Expires
The central actions of GLP-1 underline its role in the integrated control of metabolism and behaviour, as well as a treatment strategy for disorders of maladaptive reward behaviours (chronic hyperphagia and substance abuse)
Progress tracking is psychologically important during GLP-1 protocols because results often feel slower than expected in the early weeks
